Lentiviral delivery of RNAi effectors against HIV-1

Current Topics in Medicinal Chemistry

Volumn 9, Issue 12, 2009, Pages 1130-1143

  Liu, Ying Poi ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LENTIVIRUS VECTOR; MICRORNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; REVIEW; RNA INTERFERENCE; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; PHYSIOLOGY;

ANTI-HIV AGENTS; DRUG DELIVERY SYSTEMS; HIV INFECTIONS; HIV-1; HUMANS; LENTIVIRUS; RNA INTERFERENCE; VIRUS REPLICATION;

EID: 74049153868     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802609789630866     Document Type: Review

References (200)

1. McElrath, M. J.; De Rosa, S. C.; Moodie, Z.; Dubey, S.; Kierstead, L.; Janes, H.; Defawe, O. D.; Carter, D. K.; Hural, J.; Akondy, R.; Buchbinder, S. P.; Robertson, M. N.; Mehrotra, D. V.; Self, S. G.; Corey, L.; Shiver, J. W.; Casimiro, D. R. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis, Lancet 2008, 372(9653), 1894-1905.
2. Flynn, N. M.; Forthal, D. N.; Harro, C. D.; Judson, F. N.; Mayer, K. H.; Para, M. F. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infec. Dis. 2005, 191(5), 654-665.
3. Pitisuttithum, P.; Gilbert, P.; Gurwith, M.; Heyward, W.; Martin, M.; van, G. F.; Hu, D.; Tappero, J. W.; Choopanya, K. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infec. Dis. 2006, 194(12), 1661-1671.
4. Trinvuthipong, C. Thailand's Prime-Boost HIV Vaccine Phase III. Science 2004, 303(5660), 954-955.
5. Buchbinder, S. P.; Mehrotra, D. V.; Duerr, A.; Fitzgerald, D. W.; Mogg, R.; Li, D.; Gilbert, P. B.; Lama, J. R.; Marmor, M.; Del, R. C.; McElrath, M. J.; Casimiro, D. R.; Gottesdiener, K. M.; Chodakewitz, J. A.; Corey, L.; Robertson, M. N. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008, 372(9653), 1881-1893.
6. Deeks, S. G. Antiretroviral treatment of HIV infected adults. BMJ 2006, 332(7556), 1489.
7. Bartlett, J. A.; Fath, M. J.; DeMasi, R.; Hermes, A.; Quinn, J.; Mondou, E.; Rousseau, F. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS 2006, 20(16), 2051-2064.
8. Richman, D. D. HIV chemotherapy. Nature 2001, 410(6831), 995-1001.
9. Little, S. J.; Holte, S.; Routy, J. P.; Daar, E. S.; Markowitz, M.; Collier, A. C.; Koup, R. A.; Mellors, J. W.; Connick, E.; Conway, B.; Kilby, M.; Wang, L.; Whitcomb, J. M.; Hellmann, N. S.; Richman, D. D. Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med. 2002, 347(6), 385-394.
10. Lafeuillade, A.; Khiri, H.; Chadapaud, S.; Hittinger, G.; Halfon, P. Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART. AIDS 2001, 15(15), 1965-1969.
11. Jacque, J. M.; Triques, K.; Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418(6896), 435-438.
12. Haasnoot, P. C. J.; Berkhout, B. RNA interference: Its use as antiviral therapy., in Handbook of Experimental Pharmacology, Springer-Verlag Berlin Heidelberg: Heidelberg 2006, 173, 117-150.
13. Waterhouse, P. M.; Wang, M. B.; Lough, T. Gene silencing as an adaptive defence against viruses. Nature 2001, 411(6839), 834-842.
14. Voinnet, O. RNA silencing as a plant immune system against viruses. Trends in Genet. 2001, 17(8), 449-459.
15. Wilkins, C.; Dishongh, R.; Moore, S. C.; Whitt, M. A.; Chow, M.; Machaca, K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 2005, 436(7053), 1044-1047.
16. Wang, X. H.; Aliyari, R.; Li, W. X.; Li, H. W.; Kim, K.; Carthew, R.; Atkinson, P.; Ding, W. RNA interference directs innate immunity against viruses in adult Drosophila. Science 2006, 312, 452-454.
17. Segers, G. C.; Zhang, X.; Deng, F.; Sun, Q.; Nuss, D. L. Evidence that RNA silencing functions as an antiviral defense mechanism in fungi. Proc. Natl. Acad. Sci. USA 2007, 104(31), 12902-12906.
18. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391(6669), 806-811.
19. Hammond, S. M.; Caudy, A. A.; Hannon, G. J. Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2001, 2(2), 110-119.
20. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; Kim, V. N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425(6956), 415-419.
21. Denli, A. M.; Tops, B. B.; Plasterk, R. H.; Ketting, R. F.; Hannon, G. J. Processing of primary microRNAs by the microprocessor complex. Nature 2004, 432(7014), 231-235.
22. Han, J.; Lee, Y.; Yeom, K. H.; Kim, Y. K.; Jin, H.; Kim, V. N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004, 18(24), 3016-3027.
23. Zeng, Y.; Yi, R.; Cullen, B. R. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 2005, 24(1), 138-148.
24. Gregory, R. I.; Yan, K. P.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432(7014), 235-240.
25. Yi, R.; Qin, Y.; Macara, I. G.; Cullen, B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17(24), 3011-3016.
26. Lund, E.; Guttinger, S.; Calado, A.; Dahlberg, J. E.; Kutay, U. Nuclear export of microRNA precursors. Science 2004, 303(5654), 95-98.
27. Chendrimada, T. P.; Gregory, R. I.; Kumaraswamy, E.; Norman, J.; Cooch, N.; Nishikura, K.; Shiekhattar, R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436(7051), 740-744.
28. Haase, A. D.; Jaskiewicz, L.; Zhang, H.; Laine, S.; Sack, R.; Gatignol, A.; Filipowicz, W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005, 6(10), 961-967.
29. Lee, Y.; Hur, I.; Park, S. Y.; Kim, Y. K.; Suh, M. R.; Kim, V. N. The role of PACT in the RNA silencing pathway. EMBO J. 2006, 25(3), 522-532.
30. Preall, J. B.; Sontheimer, E. J. RNAi: RISC gets loaded. Cell 2005, 123(4), 543-545.
31. Hutvagner, G.; Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex, Science 2002, 297(5589), 2056-2060.
32. Mourelatos, Z.; Dostie, J.; Paushkin, S.; Sharma, A.; Charroux, B.; Abel, L.; Rappsilber, J.; Mann, M.; Dreyfuss, G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002, 16(6), 720-728.
33. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da, P., I; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions. Nat.Genet. 2005, 37(5), 495-500.
34. Brennecke, J.; Stark, A.; Russell, R. B.; Cohen, S. M. Principles of microRNA-target recognition. PLoS. Biol. 2005, 3(3), e85.
35. Grimson, A.; Farh, K. K.; Johnston, W. K.; Garrett-Engele, P.; Lim, L. P.; Bartel, D. P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27(1), 91-105.
36. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B. Prediction of mammalian microRNA targets. Cell 2003, 115(7), 787-798.
37. Yekta, S.; Shih, I. H.; Bartel, D. P. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004, 304(5670), 594-596.
38. Haasnoot, J.; Westerhout, E. M.; Berkhout, B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 2007, 25(12), 1435-1443.
39. Kim, D. H.; Rossi, J. J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 2007, 8(3), 173-184.
40. Caplen, N. J.; Parrish, S.; Imani, F.; Fire, A.; Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 2001, 98(17), 9742-9747.
41. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411(6836), 494-498.
42. Williams, B. R. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 1997, 25(2), 509-513.
43. Stark, G. R.; Kerr, I. M.; Williams, B. R.; Silverman, R. H.; Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67 227-264.
44. Tuschl, T.; Borkhardt, A. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol. Interv. 2002, 2(3), 158-167.
45. Holen, T.; Amarzguioui, M.; Wiiger, M. T.; Babaie, E.; Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 2002, 30(8), 1757-1766.
46. Morrissey, D. V.; Lockridge, J. A.; Shaw, L.; Blanchard, K.; Jensen, K.; Breen, W.; Hartsough, K.; Machemer, L.; Radka, S.; Jadhav, V.; Vaish, N.; Zinnen, S.; Vargeese, C.; Bowman, K.; Shaffer, C. S.; Jeffs, L. B.; Judge, A.; Maclachlan, I.; Polisky, B. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat.Biotechnol. 2005, 23(8), 1002-1007.
47. Morrissey, D. V.; Blanchard, K.; Shaw, L.; Jensen, K.; Lockridge, J. A.; Dickinson, B.; McSwiggen, J. A.; Vargeese, C.; Bowman, K.; Shaffer, C. S.; Polisky, B. A.; Zinnen, S. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 2005, 41(6), 1349-1356.
48. Rana, T. M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 2007, 8(1), 23-36.
49. Czauderna, F.; Fechtner, M.; Dames, S.; Aygun, H.; Klippel, A.; Pronk, G. J.; Giese, K.; Kaufmann, J. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 2003, 31(11), 2705-2716.
50. Layzer, J. M.; McCaffrey, A. P.; Tanner, A. K.; Huang, Z.; Kay, M. A.; Sullenger, B. A. In vivo activity of nuclease-resistant siRNAs. RNA 2004, 10(5), 766-771.
51. Brummelkamp, T. R.; Bernards, R.; Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296(5567), 550-553.
52. Siolas, D.; Lerner, C.; Burchard, J.; Ge, W.; Linsley, P. S.; Paddison, P. J.; Hannon, G. J.; Cleary, M. A. Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 2005, 23(2), 227-231.
53. Paddison, P. J.; Caudy, A. A.; Bernstein, E.; Hannon, G. J.; Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 2002, 16(8), 948-958.
54. Kawasaki, H.; Taira, K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 2003, 31(2), 700-707.
55. Szulc, J.; Wiznerowicz, M.; Sauvain, M. O.; Trono, D.; Aebischer, P. A versatile tool for conditional gene expression and knockdown. Nat. Methods 2006, 3(2), 109-116.
56. Zeng, Y.; Wagner, E. J.; Cullen, B. R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 2002, 9(6), 1327-1333.
57. Doench, J. G.; Petersen, C. P.; Sharp, P. A. siRNAs can function as miRNAs. Genes Dev. 2003, 17(4), 438-442.
58. Zeng, Y.; Yi, R.; Cullen, B. R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA 2003, 100(17), 9779-9784.
59. Silva, J. M.; Li, M. Z.; Chang, K.; Ge, W.; Golding, M. C.; Rickles, R. J.; Siolas, D.; Hu, G.; Paddison, P. J.; Schlabach, M. R.; Sheth, N.; Bradshaw, J.; Burchard, J.; Kulkarni, A.; Cavet, G.; Sachidanandam, R.; McCombie, W. R.; Cleary, M. A.; Elledge, S. J.; Hannon, G. J. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 2005, 37(11), 1281-1288.
60. Liu, Y. P.; Haasnoot, J.; Ter Brake, O.; Berkhout, B.; Konstantinova, P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 2008, 36(9), 2811-2824.
61. Lee, Y.; Kim, M.; Han, J.; Yeom, K. H.; Lee, S.; Baek, S. H.; Kim, V. N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23(20), 4051-4060.
62. Borchert, G. M.; Lanier, W.; Davidson, B. L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13(12), 1097-1101.
63. Grimm, D.; Streetz, K. L.; Jopling, C. L.; Storm, T. A.; Pandey, K.; Davis, C. R.; Marion, P.; Salazar, F.; Kay, M. A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441(7092), 537-541.
64. Khan, A. A.; Betel, D.; Miller, M. L.; Sander, C.; Leslie, C. S.; Marks, D. S. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009, 27(6), 549-555.
65. Baek, D.; Villen, J.; Shin, C.; Camargo, F. D.; Gygi, S. P.; Bartel, D. P. The impact of microRNAs on protein output. Nature 2008, 455(7209), 64-71
66. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455(7209), 58-63
67. Bridge, A. J.; Pebernard, S.; Ducraux, A.; Nicoulaz, A. L.; Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 2003, 34(3), 263-264.
68. Sledz, C. A.; Holko, M.; de Veer, M. J.; Silverman, R. H.; Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 2003, 5(9), 834-839.
69. Haasnoot, P. C. J.; Cupac, D.; Berkhout, B. Inhibition of virus replication by RNA interference. J. Biomed. Sci. 2003, 10, 607-616.
70. Gupta, S.; Schoer, R. A.; Egan, J. E.; Hannon, G. J.; Mittal, V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 2004, 101(7), 1927-1932.
71. Boden, D.; Pusch, O.; Lee, F.; Tucker, L.; Ramratnam, B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 2003, 77(21), 11531-11535.
72. Das, A. T.; Brummelkamp, T. R.; Westerhout, E. M.; Vink, M.; Madiredjo, M.; Bernards, R.; Berkhout, B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 2004, 78(5), 2601-2605.
73. Goudsmit, J.; Back, N. K. T.; Nara, P. L. Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB J. 1991, 5(10), 2427-2436.
74. Westerhout, E. M.; Ooms, M.; Vink, M.; Das, A. T.; Berkhout, B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005, 33(2), 796-804.
75. Leonard, J. N.; Shah, P. S.; Burnett, J. C.; Schaffer DV HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host. Microbe. 2008, 4(5), 484-494.
76. Berkhout, B.; Verhoef, K.; van Wamel, J. L. B.; Back, B. Genetic instability of live-attenuated HIV-1 vaccine strains. J. Virol. 1999, 73 1138-1145.
77. Berkhout, B. A new Houdini act: multiple routes for HIV-1 escape from RNA interference mediated inhibition. Future Microbiol. 2009, in press.
78. Randall, G.; Grakoui, A.; Rice, C. M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad .Sci. USA 2003, 100(1), 235-240.
79. De, F. R.; Migliaccio, G. Challenges and successes in developing new therapies for hepatitis C. Nature 2005, 436(7053), 953-960.
80. Xu, D.; McCarty, D.; Fernandes, A.; Fisher, M.; Samulski, R. J.; Juliano, R. L. Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector. Mol. Ther. 2005, 11(4), 523-530.
81. Zheng, Z. M.; Tang, S.; Tao, M. Development of resistance to RNAi in mammalian cells. Annals NY. Acad. Sci. 2005, 1058, 105-118.
82. Coburn, G. A.; Cullen, B. R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 2002, 76(18), 9225-9231.
83. Capodici, J.; Kariko, K.; Weissman, D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 2002, 169(9), 5196-5201.
84. Joshi, P. J.; North, T. W.; Prasad, V. R. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol. Ther. 2005, 11(5), 677-686.
85. Nishitsuji, H.; Kohara, M.; Kannagi, M.; Masuda, T. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J. Virol. 2006, 80(15), 7658-7666.
86. Surabhi, R. M.; Gaynor, R. B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 2002, 76(24), 12963-12973.
87. Hu, W. Y.; Myers, C. P.; Kilzer, J. M.; Pfaff, S. L.; Bushman, F. D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 2002, 12(15), 1301-1311.
88. Nishitsuji, H.; Ikeda, T.; Miyoshi, H.; Ohashi, T.; Kannagi, M.; Masuda, T. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microb. Infect. 2004, 6(1), 76-85.
89. Westerhout, E. M.; Ter Brake, O.; Berkhout, B. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 2006, 3, 57-65.
90. Brake, O. t.; Berkhout, B. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. J. RNAi Gene Silencing 2005, 1, 56-65.
91. Qin, X. F.; An, D. S.; Chen, I. S. Y.; Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 2003, 100(1), 183-188.
92. Arrighi, J. F.; Pion, M.; Garcia, E.; Escola, J. M.; van Kooyk, Y.; Geijtenbeek, T. B.; Piguet, V. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 2004, 200(10), 1279-1288.
93. Liu, S.; Asparuhova, M.; Brondani, V.; Ziekau, I.; Klimkait, T.; Schumperli, D. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res. 2004, 32(12), 3752-3759.
94. Ping, Y. H.; Chu, C. Y.; Cao, H.; Jacque, J. M.; Stevenson, M.; Rana, T. M. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology 2004, 1, 46.
95. Zhou, N.; Fang, J.; Mukhtar, M.; Acheampong, E.; Pomerantz, R. J. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. Gene Ther. 2004, 11(23), 1703-1712.
96. Eugen-Olsen, J.; Iversen, A. K.; Garred, P.; Koppelhus, U.; Pedersen, C.; Benfield, T. L.; Sorensen, A. M.; Katzenstein, T.; Dickmeiss, E.; Gerstoft, J.; Skinhoj, P.; Svejgaard, A.; Nielsen, J. O.; Hofmann, B. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997, 11(3), 305-310.
97. Garred, P.; Eugen-Olsen, J.; Iversen, A. K.; Benfield, T. L.; Svejgaard, A.; Hofmann, B. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet 1997, 349(9069), 1884.
98. Samson, M.; Libert, F.; Doranz, B. J.; Rucker, J.; Liesnard, C.; Farber, C.-M.; Saragosti, S.; Lapoumeroulie, C.; Cognaux, J.; Forceille, C.; Muyldermans, G.; Verhofstede, C.; Burtonboy, G.; Georges, M.; Imai, T.; Rana, S.; Yi, Y.; Smyth, R. J.; Collman, R. G.; Doms, R. W.; Vassart, G.; Parmentier, M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382, 722-725.
99. Liu, R.; Paxton, W. A.; Choe, S.; Ceradini, D.; Martin, S. R.; Horuk, R.; MacDonald, M. E.; Stuhlmann, H.; Koup, R. A.; Landau, N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86(3), 367-377.
100. Arien, K. K.; Abraha, A.; Quinones-Mateu, M. E.; Kestens, L.; Vanham, G.; Arts, E. J. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 2005, 79(14), 8979-8990.
101. Anderson, J.; Akkina, R. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology 2005, 2 53.
102. Lapidot, T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann. NY Acad. Sci. 2001, 938 83-95.
103. Kahn, J.; Byk, T.; Jansson-Sjostrand, L.; Petit, I.; Shivtiel, S.; Nagler, A.; Hardan, I.; Deutsch, V.; Gazit, Z.; Gazit, D.; Karlsson, S.; Lapidot, T. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 2004, 103(8), 2942-2949.
104. Matzke, M. A.; Birchler, J. A. RNAi-mediated pathways in the nucleus. Nat. Rev. Genet. 2005, 6(1), 24-35.
105. Wassenegger, M. The role of the RNAi machinery in heterochromatin formation. Cell 2005, 122(1), 13-16.
106. Morris, K. V.; Chan, S. W.; Jacobsen, S. E.; Looney, D. J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004, 305(5688), 1289-1292.
107. Kim, D. H.; Villeneuve, L. M.; Morris, K. V.; Rossi, J. J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 2006, 13(9), 793-797.
108. Janowski, B. A.; Huffman, K. E.; Schwartz, J. C.; Ram, R.; Nordsell, R.; Shames, D. S.; Minna, J. D.; Corey, D. R. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat. Struct. Mol. Biol. 2006, 13(9), 787-792.
109. Buhler, M.; Mohn, F.; Stalder, L.; Muhlemann, O. Transcriptional silencing of nonsense codon-containing immunoglobulin minigenes. Mol. Cell 2005, 18(3), 307-317.
110. Ting, A. H.; Schuebel, K. E.; Herman, J. G.; Baylin, S. B. Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet. 2005, 37(8), 906-910.
111. Weinberg, M. S.; Villeneuve, L. M.; Ehsani, A.; Amarzguioui, M.; Aagaard, L.; Chen, Z. X.; Riggs, A. D.; Rossi, J. J.; Morris, K. V. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA. 2006, 12(2), 256-262.
112. Hawkins, P. G.; Santoso, S.; Adams, C.; Anest, V.; Morris, K. V. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res. 2009, 37(9), 2984-2995.
113. Gonzalez, S.; Pisano, D. G.; Serrano, M. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle 2008, 7(16), 2601-2608.
114. Kim, D. H.; Saetrom, P.; Snove, O., Jr.; Rossi, J. J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. USA 2008, 105(42), 16230-16235.
115. Li, F.; Ding, S. W. Virus counterdefense: diverse strategies for evading the RNA-silencing immunity. Annu. Rev. Microbiol. 2006, 60 503-531.
116. de Vries, W.; Berkhout, B. RNAi suppressors encoded by pathogenic human viruses. Int. J. Biochem. Cell Biol. 2008, 40(10), 2007-2012.
117. Lecellier, C. H.; Dunoyer, P.; Arar, K.; Lehmann-Che, J.; Eyquem, S.; Himber, C.; Saib, A.; Voinnet, O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308(5721), 557-560.
118. Bennasser, Y.; Le, S. Y.; Benkirane, M.; Jeang, K. T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22(5), 607-619.
119. Andersson, M. G.; Haasnoot, P. C. J.; Xu, N.; Berenjian, S.; Berkhout, B.; Akusjarvi, G. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 2005, 79(15), 9556-9565.
120. Haasnoot, J.; de Vries, W.; Geutjes, E. J.; Prins, M.; de Haan, P.; Berkhout, B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 2007, 3(6), e86.
121. Li, W. X.; Li, H.; Lu, R.; Li, F.; Dus, M.; Atkinson, P.; Brydon, E. W.; Johnson, K. L.; Garcia-Sastre, A.; Ball, L. A.; Palese, P.; Ding, S. W. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. USA 2004, 101(5), 1350-1355.
122. Lu, S.; Cullen, B. R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J. Virol. 2004, 78(23), 12868-12876.
123. Wang, Y.; Kato, N.; Jazag, A.; Dharel, N.; Otsuka, M.; Taniguchi, H.; Kawabe, T.; Omata, M. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 2006, 130(3), 883-892.
124. Otsuka, M.; Jing, Q.; Georgel, P.; New, L.; Chen, J.; Mols, J.; Kang, Y. J.; Jiang, Z.; Du, X.; Cook, R.; Das, S. C.; Pattnaik, A. K.; Beutler, B.; Han, J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27(1), 123-134.
125. Huang, J.; Wang, F.; Argyris, E.; Chen, K.; Liang, Z.; Tian, H.; Huang, W.; Squires, K.; Verlinghieri, G.; Zhang, H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nat. Med. 2007, 13(10), 1241-1247.
126. Grimm, D.; Kay, M. A. Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol. Ther. 2007, 15(5), 878-888.
127. Liu, Y. P.; Berkhout, B. Combinatorial RNAi strategies against HIV-1 and other escape-prone viruses. Int. J. BioSci.Technol. 2008, 1(2), 1-10.
128. Berkhout, B. RNA interference as an antiviral approach: targeting HIV-1. Curr. Opin. Mol. Ther. 2004, 6(2), 141-145.
129. Ter Brake, O.; Konstantinova, P.; Ceylan, M.; Berkhout, B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 2006, 14(6), 883-892.
130. Lisziewicz, J.; Sun, D.; Klotman, M.; Agrawal, S.; Zamecnik, P.; Gallo, R. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. Proc. Natl. Acad. Sci. USA 1992, 89(23), 11209-11213.
131. Bertrand, E.; Pictet, R.; Grange, T. Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 1994, 22(3), 293-300.
132. Ohkawa, J.; Yuyama, N.; Takebe, Y.; Nishikawa, S.; Taira, K. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1993, 90(23), 11302-11306.
133. Ter Brake, O.; 't Hooft, K.; Liu, Y. P.; Centlivre, M.; von Eije, K. J.; Berkhout, B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 Inhibition. Mol. Ther. 2008, 16(3), 557-564.
134. Liu, Y. P.; Haasnoot, J.; Berkhout, B. Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res. 2007, 35(17), 5683-5693.
135. Saayman, S.; Barichievy, S.; Capovilla, A.; Morris, K. V.; Arbuthnot, P.; Weinberg, M. S. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008, 3(7), e2602.
136. Sano, M.; Li, H.; Nakanishi, M.; Rossi, J. J. Expression of long anti-HIV-1 hairpin RNAs for the generation of multiple siRNAs: advantages and limitations. Mol. Ther. 2008, 16(1), 170-177.
137. Konstantinova, P.; de Vries, W.; Haasnoot, J.; Ter Brake, O.; de Haan, P.; Berkhout, B. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther. 2006, 13(19), 1403-1413.
138. Barichievy, S.; Saayman, S.; von Eije, K. J.; Morris, K. V.; Arbuthnot, P.; Weinberg, M. S. The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5′ long terminal repeat. Oligonucleotides 2007, 17(4), 419-431.
139. Weinberg, M. S.; Ely, A.; Barichievy, S.; Crowther, C.; Mufamadi, S.; Carmona, S.; Arbuthnot, P. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol. Ther. 2007, 15(3), 534-541.
140. Akashi, H.; Miyagishi, M.; Yokota, T.; Watanabe, H.; Hino, T.; Nishina, K.; Kohara, M.; Taira, K. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol. BioSyst. 2005, 1(5-6), 382-390.
141. Watanabe, T.; Sudoh, M.; Miyagishi, M.; Akashi, H.; Arai, M.; Inoue, K.; Taira, K.; Yoshiba, M.; Kohara, M. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther. 2006, 13(11), 883-892.
142. Boden, D.; Pusch, O.; Silbermann, R.; Lee, F.; Tucker, L.; Ramratnam, B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 2004, 32(3), 1154-1158.
143. Qu, J.; Ye, J.; Fang, R. Artificial microRNA-mediated virus resistance in plants. J. Virol. 2007, 81(12), 6690-6699.
144. Xia, H.; Mao, Q.; Paulson, H. L.; Davidson, B. L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 2002, 20(10), 1006-1010.
145. Stegmeier, F.; Hu, G.; Rickles, R. J.; Hannon, G. J.; Elledge, S. J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 2005, 102(37), 13212-13217.
146. Shin, K. J.; Wall, E. A.; Zavzavadjian, J. R.; Santat, L. A.; Liu, J.; Hwang, J. I.; Rebres, R.; Roach, T.; Seaman, W.; Simon, M. I.; Fraser, I. D. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. USA 2006, 103(37), 13759-13764.
147. McBride, J. L.; Boudreau, R. L.; Harper, S. Q.; Staber, P. D.; Monteys, A. M.; Martins, I.; Gilmore, B. L.; Burstein, H.; Peluso, R. W.; Polisky, B.; Carter, B. J.; Davidson, B. L. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. USA 2008, 105(15), 5868-5873.
148. Castanotto, D.; Sakurai, K.; Lingeman, R.; Li, H.; Shively, L.; Aagaard, L.; Soifer, H.; Gatignol, A.; Riggs, A.; Rossi, J. J. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 2007, 35(15), 5154-5164.
149. Bauer, M.; Kinkl, N.; Meixner, A.; Kremmer, E.; Riemenschneider, M.; Forstl, H.; Gasser, T.; Ueffing, M. Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther. 2009, 16(1), 142-147.
150. Sun, D.; Melegari, M.; Sridhar, S.; Rogler, C. E.; Zhu, L. Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. Biotechniques 2006, 41(1), 59-63.
151. Aagaard, L. A.; Zhang, J.; von Eije, K. J.; Li, H.; Saetrom, P.; Amarzguioui, M.; Rossi, J. J. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther. 2008, 15(23), 1536-1549.
152. Gervaix, A.; West, D.; Leoni, L. M.; Richman, D. D.; Wong-Staal, F.; Corbeil, J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA 1997, 94(9), 4653-4658.
153. Yam, P. Y.; Li, S.; Wu, J.; Hu, J.; Zaia, J. A.; Yee, J. K. Design of HIV vectors for efficient gene delivery into human hematopoietic cells. Mol. Ther. 2002, 5(4), 479-484.
154. Greber, U. F.; Fassati, A. Nuclear import of viral DNA genomes. Traffic 2003, 4(3), 136-143.
155. Wu, X.; Li, Y.; Crise, B.; Burgess, S. M. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300(5626), 1749-1751.
156. Chun, T. W.; Carruth, L.; Finzi, D.; Shen, X.; DiGiuseppe, J. A.; Taylor, H.; Hermankova, M.; Chadwick, K.; Margolick, J.; Quinn, T. C.; Kuo, Y. H.; Brookmeyer, R.; Zeiger, M. A.; Barditch-Crovo, P.; Siliciano, R. F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387(6629), 183-188.
157. Rouzine, I. M.; Coffin, J. M. Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J. Virol. 1999, 73(10), 8167-8178.
158. Naldini, L.; Blomer, U.; Gallay, P.; Ory, D.; Mulligan, R.; Gage, F. H.; Verma, I. M.; Trono, D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272, 263-267.
159. Akkina, R. K.; Walton, R. M.; Chen, M. L.; Li, Q. X.; Planelles, V.; Chen, I. S. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 1996, 70(4), 2581-2585.
160. Reiser, J.; Harmison, G.; Kluepfel-Stahl, S.; Brady, R. O.; Karlsson, S.; Schubert, M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 1996, 93(26), 15266-15271.
161. Naldini, L. Lentiviruses as gene transfer agents for delivery to nondividing cells. Curr. Opin. Biotechnol. 1998, 9(5), 457-463.
162. Dull, T.; Zufferey, R.; Kelly, M.; Mandel, R. J.; Nguyen, M.; Trono, D.; Naldini, L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 1998, 72(11), 8463-8471.
163. Miyoshi, H.; Blomer, U.; Takahashi, M.; Gage, F. H.; Verma, I. M. Development of a self-inactivating lentivirus vector. J. Virol. 1998, 72(10), 8150-8157.
164. Zufferey, R.; Dull, T.; Mandel, R. J.; Bukovsky, A.; Quiroz, D.; Naldini, L.; Trono, D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 1998, 72(12), 9873-9880.
165. Iwakuma, T.; Cui, Y.; Chang, L.-J. Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 1999, 261, 120-132.
166. Bukovsky, A. A.; Song, J. P.; Naldini, L. Interaction of human immunodeficiency virus-derived vectors with wild- type virus in transduced cells. J. Virol. 1999, 73(8), 7087-7092.
167. Charneau, P.; Mirambeau, G.; Roux, P.; Paulous, S.; Buc, H.; Clavel, F.
168. Zennou, V.; Petit, C.; Guetard, D.; Nerhbass, U.; Montagnier, L.; Charneau, P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101(2), 173-185.
169. Follenzi, A.; Ailles, L. E.; Bakovic, S.; Geuna, M.; Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat.Genet. 2000, 25(2), 217-222.
170. Sirven, A.; Pflumio, F.; Zennou, V.; Titeux, M.; Vainchenker, W.; Coulombel, L.; Dubart-Kupperschmitt, A.; Charneau, P. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 2000, 96(13), 4103-4110.
171. Dardalhon, V.; Herpers, B.; Noraz, N.; Pflumio, F.; Guetard, D.; Leveau, C.; Dubart-Kupperschmitt, A.; Charneau, P.; Taylor, N. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 2001, 8(3), 190-198.
172. Patzel, V.; Sczakiel, G. The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure. Biochem.Biophy. Res. Commun. 1997, 231(3), 864-867.
173. Donello, J. E.; Loeb, J. E.; Hope, T. J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 1998, 72(6), 5085-5092.
174. Deglon, N.; Tseng, J. L.; Bensadoun, J. C.; Zurn, A. D.; Arsenijevic, Y.; Pereira de, A. L.; Zufferey, R.; Trono, D.; Aebischer, P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 2000, 11(1), 179-190.
175. Zufferey, R.; Donello, J. E.; Trono, D.; Hope, T. J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 1999, 73(4), 2886-2892.
176. Higashimoto, T.; Urbinati, F.; Perumbeti, A.; Jiang, G.; Zarzuela, A.; Chang, L. J.; Kohn, D. B.; Malik, P. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Ther. 2007, 14(17), 1298-1304.
177. Follenzi, A.; Battaglia, M.; Lombardo, A.; Annoni, A.; Roncarolo, M. G.; Naldini, L. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004, 103(10), 3700-3709.
178. Kordower, J. H.; Emborg, M. E.; Bloch, J.; Ma, S. Y.; Chu, Y.; Leventhal, L.; McBride, J.; Chen, E. Y.; Palfi, S.; Roitberg, B. Z.; Brown, W. D.; Holden, J. E.; Pyzalski, R.; Taylor, M. D.; Carvey, P.; Ling, Z.; Trono, D.; Hantraye, P.; Deglon, N.; Aebischer, P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290(5492), 767-773.
179. Miyoshi, H.; Smith, K. A.; Mosier, D. E.; Verma, I. M.; Torbett, B. E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999, 283(5402), 682-686.
180. Nguyen, T. H.; Oberholzer, J.; Birraux, J.; Majno, P.; Morel, P.; Trono, D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol. Ther. 2002, 6(2), 199-209.
181. Kafri, T.; Blomer, U.; Peterson, D. A.; Gage, F. H.; Verma, I. M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 1997, 17(3), 314-317.
182. Gaspar, H. B.; Thrasher, A. J. Gene therapy for severe combined immunodeficiencies. Exp. Opin. Biol. Ther. 2005, 5(9), 1175-1182.
183. Hacein-Bey-Abina, S.; Garrigue, A.; Wang, G. P.; Soulier, J.; Lim, A.; Morillon, E.; Clappier, E.; Caccavelli, L.; Delabesse, E.; Beldjord, K.; Asnafi, V.; Macintyre, E.; Dal, C. L.; Radford, I.; Brousse, N.; Sigaux, F.; Moshous, D.; Hauer, J.; Borkhardt, A.; Belohradsky, B. H.; Wintergerst, U.; Velez, M. C.; Leiva, L.; Sorensen, R.; Wulffraat, N.; Blanche, S.; Bushman, F. D.; Fischer, A.; Cavazzana-Calvo, M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 2008, 118(9), 3132-3142.
184. Macpherson, J. L.; Boyd, M. P.; Arndt, A. J.; Todd, A. V.; Fanning, G. C.; Ely, J. A.; Elliott, F.; Knop, A.; Raponi, M.; Murray, J.; Gerlach, W.; Sun, L. Q.; Penny, R.; Symonds, G. P.; Carr, A.; Cooper, D. A. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. J. Gene Med. 2005, 7(5), 552-564.
185. Amado, R. G.; Mitsuyasu, R. T.; Rosenblatt, J. D.; Ngok, F. K.; Bakker, A.; Cole, S.; Chorn, N.; Lin, L. S.; Bristol, G.; Boyd, M. P.; Macpherson, J. L.; Fanning, G. C.; Todd, A. V.; Ely, J. A.; Zack, J. A.; Symonds, G. P. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 2004, 15(3), 251-262.
186. Mitsuyasu, R. T.; Merigan, T. C.; Carr, A.; Zack, J. A.; Winters, M. A.; Workman, C.; Bloch, M.; Lalezari, J.; Becker, S.; Thornton, L.; Akil, B.; Khanlou, H.; Finlayson, R.; McFarlane, R.; Smith, D. E.; Garsia, R.; Ma, D.; Law, M.; Murray, J. M.; von Kalle, C.; Ely, J. A.; Patino, S. M.; Knop, A. E.; Wong, P.; Todd, A. V.; Haughton, M.; Fuery, C.; Macpherson, J. L.; Symonds, G. P.; Evans, L. A.; Pond, S. M.; Cooper, D. A. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34(+) cells. Nat. Med. 2009, 15 285-292.
187. Levine, B. L.; Humeau, L. M.; Boyer, J.; MacGregor, R. R.; Rebello, T.; Lu, X.; Binder, G. K.; Slepushkin, V.; Lemiale, F.; Mascola, J. R.; Bushman, F. D.; Dropulic, B.; June, C. H. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Nat. Acad. Sci. USA 2006, 103(46), 17372-17377.
188. Wang, G. P.; Levine, B. L.; Binder, G. K.; Berry, C. C.; Malani, N.; McGarrity, G.; Tebas, P.; June, C. H.; Bushman, F. D. Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells. Mol. Ther. 2009, 17(5), 844-850.
189. Li, M. J.; Kim, J.; Li, S.; Zaia, J.; Yee, J. K.; Anderson, J.; Akkina, R.; Rossi, J. J. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol. Ther. 2005, 12(5), 900-909.
190. Banerjea, A.; Li, M. J.; Bauer, G.; Remling, L.; Lee, N. S.; Rossi, J.; Akkina, R. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 2003, 8(1), 62-71.
191. Chang, L. J.; Liu, X.; He, J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther. 2005, 12(14), 1133-1144.
192. Ter Brake, O.; Berkhout, B. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J. Gene Med. 2007, 9(9), 743-750.
193. Kotsopoulou, E.; Kim; V.N.; Kingsman, A. J.; Kingsman, S. M.; Mitrophanous, K. A. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 2000, 74 4839-4852.
194. de Vries, W.; Haasnoot, J.; van, d., V; van Montfort, T.; Zorgdrager, F.; Paxton, W.; Cornelissen, M.; van Kuppeveld, F.; de Haan, P.; Berkhout, B. Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther. 2008, 15(7), 545-552.
195. Westerhout, E. M.; Berkhout, B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res. 2007, 35(13), 4322-4330.
196. Schubert, S.; Grunweller, A.; Erdmann, V. A.; Kurreck, J. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J. Mol. Biol.2005, 348(4), 883-893.
197. Brown, K. M.; Chu, C. Y.; Rana, T. M. Target accessibility dictates the potency of human RISC. Nat. Struct. Mol. Biol. 2005, 12(5), 469-470.
198. Poluri, A.; Sutton, R. E. Titers of HIV-based vectors encoding shRNAs are reduced by a Dicer-dependent mechanism. Mol. Ther. 2007, 16 378-386.
199. Hornung, V.; Guenthner-Biller, M.; Bourquin, C.; Ablasser, A.; Schlee, M.; Uematsu, S.; Noronha, A.; Manoharan, M.; Akira, S.; de, F. A.; Endres, S.; Hartmann, G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005, 11(3), 263-270.
200. Jackson, A. L.; Linsley, P. S. Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 2004, 20(11), 521-524.